Neuraxis, Inc. (NRXS) - Halal (Shariah-Compliant)
Neuraxis, Inc. (NRXS) is classified as Halal (Shariah-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
- Sector
- Healthcare
- Industry
- Biotechnology
- Result
- Pass
- Reason
- The sector "Healthcare" and industry "Biotechnology" are not in the excluded categories.
Financial Ratios
- Debt Ratio
- Value: 0.5% | Threshold: 30% | Result: Pass
- Cash & Interest-bearing Securities Ratio
- Value: 14.6% | Threshold: 30% | Result: Pass
- Non-Permissible Income Ratio
- Value: 0.0% | Threshold: 5% | Result: Pass
Dividend Purification
Purification percentage: 0.00%.No non-permissible income detected in the financial statements. No purification is required based on available data.
About Neuraxis, Inc.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Frequently Asked Questions
Is Neuraxis, Inc. (NRXS) stock halal to invest in?
According to AAOIFI Shariah screening standards, Neuraxis, Inc. (NRXS) is currently classified as Halal (Shariah-Compliant). This is based on both business activity and financial ratio screening.
Does Neuraxis, Inc. have any interest income?
Neuraxis, Inc.'s interest income ratio is 14.6% of total revenue. AAOIFI standards require this to be below 30%.

